Risk Management and Healthcare Policy
Volume 16, 2023 - Issue
REVIEW
Denosumab Use in Chronic Kidney Disease Associated Osteoporosis: A Narrative Review
Abduelmula R Abduelkarem1 Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates;2 Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab EmiratesCorrespondence[email protected]
https://orcid.org/0000-0003-4481-7779View further author information
https://orcid.org/0000-0003-4481-7779View further author information, Adnane Guella3 Department of Nephrology, University Hospital Sharjah, Sharjah, United Arab Emirateshttps://orcid.org/0000-0002-4026-4268View further author information
https://orcid.org/0000-0002-4026-4268View further author information, Amar M Hamrouni4 Department of Pharmaceutical Sciences, College of Pharmacy, Al Ain University, Al Ain, United Arab Emirateshttps://orcid.org/0000-0002-8283-5364View further author information
https://orcid.org/0000-0002-8283-5364View further author information, Mohammed M Hassanein1 Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirateshttps://orcid.org/0000-0002-3540-0595View further author information
https://orcid.org/0000-0002-3540-0595View further author information, Ahmed Nasr5 Pharmacy Department, University Hospital Sharjah, Sharjah, United Arab Emirateshttps://orcid.org/0000-0003-2770-5687View further author information
https://orcid.org/0000-0003-2770-5687View further author information & 